Vaxdyn

MainImage

116,900.00€

Invested of 500,000.00€

Nuevos tratamientos contra las infecciones resistentes a antibióticos

Finish date: 31/07/2017 Sevilla

Premoney valuation

3,500,000.00€

Percentage offered

12.50%

Est. ROI

900%

Exit horizon

2022

Understand the risks associated with your investments, review all project documentation and ask any questions you have. We will be happy to assist.